Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
Dynatronics Corporation (NASDAQ:DYNT) Rating Lowered to Strong Sell at ValuEngine
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
Separately, Zacks Investment Research raised shares of Dynatronics Corporation from a sell rating to a hold rating in a report on Tuesday, July 11th.
Dynatronics Corporation (NASDAQ:DYNT) opened at 2.70 on Monday. Dynatronics Corporation has a 12 month low of $2.29 and a 12 month high of $3.75. The firm’s market capitalization is $9.94 million. The firm has a 50-day moving average price of $2.70 and a 200 day moving average price of $2.83.
Dynatronics Corporation (NASDAQ:DYNT) last announced its quarterly earnings results on Thursday, May 18th. The medical equipment provider reported ($0.28) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by $0.08. Dynatronics Corporation had a negative net margin of 7.24% and a negative return on equity of 152.17%. The firm had revenue of $7.72 million during the quarter. On average, equities analysts forecast that Dynatronics Corporation will post ($0.85) EPS for the current year.
Dynatronics Corporation Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
To view ValuEngine’s full report, visit ValuEngine’s official website.